Palvella Therapeutics Statistics
NASDAQ: PVLAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
138.77+7.43 (+5.66%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Palvella Therapeutics by the numbers
Palvella Therapeutics has a market capitalization of $2.00 billion based on 14.41M shares outstanding. With trailing EPS of $-4.85, Palvella Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.1% below its 50-day average and 11.5% above its 200-day average.
Average daily trading volume is 211.30K shares, or about $29.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PVLA valuation vs. peer median
| Metric | PVLA | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.00B | $1.93B | +4% |
| Avg. volume | 211.30K | 1.51M | -86% |
Peer median across 8 companies: SDGR, LKFT, MLYS, PRGO, XERS, AGIO, ADRX, SRPT.
Valuation
- Market cap
- $2.00B
- EPS (TTM)
- $-4.85
- Shares outstanding
- 14.41M
Price and trading
- Previous close
- 131.34
- Open
- 130.70
- Day range
- 128.80 – 139.81
- 52-week range
- 66.58 – 161.38
- 52-week change
- +97.99%
- 50-day moving average
- 147.85
- 200-day moving average
- 124.44
- Beta
- —
- Volume
- 174.04K
- Average volume
- 211.30K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2026
Additional statistics
- Market Cap
- 2.00B
- Forward Pe
- -18.51
- Eps
- -4.85
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 161.38
- Week52 Low
- 66.58
- Avg Volume
- 211.30K
- Shares Outstanding
- 14.41M
- Ma50
- 147.85
- Ma200
- 124.44
- Earnings Date
- Aug 4, 2026
- Pct From52w High
- -14.01%
- Pct From52w Low
- 108.43%